Management of coexistent carotid and coronary artery disease

D P Halpin1, S Riggins, J D Carmichael

  • 1Department of Surgery, Baptist Medical Center-Princeton, Birmingham, Ala.

Southern Medical Journal
|February 1, 1994
PubMed

Insights

Simultaneous coronary artery bypass grafting and carotid endarterectomy (CE) is safe, even with bilateral carotid artery disease. This combined procedure for high-grade stenosis offers acceptable morbidity and mortality rates.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Vascular Surgery

Background:

  • Coronary artery disease and carotid artery disease often coexist.
  • Surgical management of both conditions requires careful consideration of patient risk.
  • The safety of combined coronary artery bypass grafting (CABG) and carotid endarterectomy (CE) is a significant clinical question.

Purpose of the Study:

  • To evaluate the safety and outcomes of simultaneous CABG and CE.
  • To assess the impact of bilateral carotid artery disease on the combined procedure's morbidity and mortality.

Main Methods:

  • A retrospective review of 133 patients undergoing simultaneous CABG and CE over 8 years.
  • Carotid endarterectomy (CE) was performed before sternotomy for CABG under the same anesthesia.
  • Patient data included preoperative symptoms, degree of stenosis, and postoperative complications.

Main Results:

  • Overall postoperative stroke/TIA rate was 4.6% (3 strokes, 3 TIAs).
  • Mortality rate was 1.5% (2 deaths).
  • No significant difference in outcomes was observed in patients with bilateral carotid artery disease compared to those with unilateral disease.

Conclusions:

  • Simultaneous CABG and CE is a viable option for patients with significant coronary and carotid artery disease.
  • Bilateral carotid artery disease does not appear to increase the risk of stroke or mortality in this combined procedure.
  • The study supports the simultaneous repair of high-grade carotid stenosis and coronary artery disease.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...